Fingerprint
Dive into the research topics of 'Overcoming proteasome inhibitor-refractory multiple myeloma with elotuzumab, bortezomib, nelfinavir, and dexamethasone'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Overcoming proteasome inhibitor-refractory multiple myeloma with elotuzumab, bortezomib, nelfinavir, and dexamethasone
Alexandra Erath, Dilan A. Patel, Eric A. Hosack, James E. Patanella, Daniel M. Ibach, Adetola A. Kassim
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations